74 related articles for article (PubMed ID: 9488040)
1. Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.
Zhang ZC; Nechushtan H; Jacob-Hirsch J; Avni D; Meyuhas O; Razin E
Oncogene; 1998 Feb; 16(6):763-9. PubMed ID: 9488040
[TBL] [Abstract][Full Text] [Related]
2. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
3. Nuclear translocation of upstream stimulating factor 2 (USF2) in activated mast cells: a possible role in their survival.
Frenkel S; Kay G; Nechushtan H; Razin E
J Immunol; 1998 Sep; 161(6):2881-7. PubMed ID: 9743349
[TBL] [Abstract][Full Text] [Related]
4. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
5. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis.
Chen N; Szentirmay MN; Pawar SA; Sirito M; Wang J; Wang Z; Zhai Q; Yang HX; Peehl DM; Ware JL; Sawadogo M
Oncogene; 2006 Jan; 25(4):579-87. PubMed ID: 16186802
[TBL] [Abstract][Full Text] [Related]
7. Constitutive c-myc expression enhances the response of murine mast cells to IL-3, but does not eliminate their requirement for growth factors.
Hume CR; Nocka KH; Sorrentino V; Lee JS; Fleissner E
Oncogene; 1988 Mar; 2(3):223-6. PubMed ID: 3281092
[TBL] [Abstract][Full Text] [Related]
8. Expression of the microphthalmia-associated basic helix-loop-helix leucine zipper transcription factor Mi in avian neuroretina cells induces a pigmented phenotype.
Planque N; Turque N; Opdecamp K; Bailly M; Martin P; Saule S
Cell Growth Differ; 1999 Jul; 10(7):525-36. PubMed ID: 10437920
[TBL] [Abstract][Full Text] [Related]
9. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
[TBL] [Abstract][Full Text] [Related]
10. Loss of USF transcriptional activity in breast cancer cell lines.
Ismail PM; Lu T; Sawadogo M
Oncogene; 1999 Sep; 18(40):5582-91. PubMed ID: 10523835
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative properties of the USF family of helix-loop-helix transcription factors.
Luo X; Sawadogo M
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1308-13. PubMed ID: 8577760
[TBL] [Abstract][Full Text] [Related]
12. DNA binding of USF is required for specific E-box dependent gene activation in vivo.
Kiermaier A; Gawn JM; Desbarats L; Saffrich R; Ansorge W; Farrell PJ; Eilers M; Packham G
Oncogene; 1999 Dec; 18(51):7200-11. PubMed ID: 10602473
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
Recio JA; Merlino G
Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
[TBL] [Abstract][Full Text] [Related]
18. Specific induction of RGS16 (regulator of G-protein signalling 16) mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor alpha in a calcium-sensitive manner.
Fong CW; Zhang Y; Neo SY; Lin SC
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):747-53. PubMed ID: 11104682
[TBL] [Abstract][Full Text] [Related]
19. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
20. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
